FDA Wants More Diversity in Clinical Trials

The U.S. Foodstuff and Drug Administration states organizations that produce medication and other medical solutions should post ideas for how they will maximize the range of Blacks and other underrepresented groups in clinical trials, the agency reported Wednesday.